These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12602496)

  • 21. In vitro release studies on matrix type transdermal drug delivery systems of naltrexone and its acetyl prodrug.
    Nalluri BN; Milligan C; Chen J; Crooks PA; Stinchcomb AL
    Drug Dev Ind Pharm; 2005 Oct; 31(9):871-7. PubMed ID: 16305998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: theoretical predictions with an oscillating diffusion coefficient model.
    Rohr UD; Saeger-Lorenz K
    J Pharm Sci; 2002 Mar; 91(3):822-44. PubMed ID: 11920768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3).
    Bakhteyar H; Cassone C; Kohan HG; Sani SN
    Int J Pharm Compd; 2017; 21(5):418-425. PubMed ID: 29216618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of Metolose structure on the free volume and the consequent metoprolol tartrate release of patches.
    Papp J; Marton S; Süvegh K; Zelkó R
    Int J Biol Macromol; 2009 Jan; 44(1):6-8. PubMed ID: 18940196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation development and in vitro evaluation of theophylline microcapsules.
    Ahmad M; Akhtar N; Murtaza G; Hussain SW
    Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An alternative method to the evaluation of similarity factor in dissolution testing.
    Costa P
    Int J Pharm; 2001 Jun; 220(1-2):77-83. PubMed ID: 11376969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release kinetics of catechins from chewing gum.
    Yang X; Wang G; Zhang X
    J Pharm Sci; 2004 Feb; 93(2):293-9. PubMed ID: 14705187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.
    Ahmed OA; Afouna MI; El-Say KM; Abdel-Naim AB; Khedr A; Banjar ZM
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1005-13. PubMed ID: 24702435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FORMULATION, EVALUATION AND IN VITRO DISSOLUTION PERFORMANCE OF ENALAPRIL MALEATE SUSTAINED RELEASE MATRICES: EFFECT OF POLYMER COMPOSITION AND VISCOSITY GRADE.
    Shah A; Khan GM; Ullah H; Khan KA; Ullah K; Khan SA
    Acta Pol Pharm; 2016 Jul; 73(4):1037-1043. PubMed ID: 29648730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of chemical permeation enhancers from drug-in-adhesive transdermal patches.
    Qvist MH; Hoeck U; Kreilgaard B; Madsen F; Frokjaer S
    Int J Pharm; 2002 Jan; 231(2):253-63. PubMed ID: 11755277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
    Latsch S; Selzer T; Fink L; Kreuter J
    Eur J Pharm Biopharm; 2003 Jul; 56(1):43-52. PubMed ID: 12837480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro release profiles of clonidine transdermal therapeutic systems and scopolamine transdermal patches.
    Shah VP; Tymes NW; Skelly JP
    Pharm Res; 1989 Apr; 6(4):346-51. PubMed ID: 2748524
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlled Electrostatic Self-Assembly of Ibuprofen-Cationic Dextran Nanoconjugates Prepared by low Energy Green Process - a Novel Delivery Tool for Poorly Soluble Drugs.
    Abioye AO; Kola-Mustapha A
    Pharm Res; 2015 Jun; 32(6):2110-31. PubMed ID: 25527142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration.
    Rao PR; Diwan PV
    Drug Dev Ind Pharm; 1998 Apr; 24(4):327-36. PubMed ID: 9876592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on screening of matrix and permeation enhancer of sustained-release patches of duliang].
    Rao Q; Lin Y; Liu X; Ma LJ; Sheng FF; Xiao K
    Zhong Yao Cai; 2014 Feb; 37(2):321-4. PubMed ID: 25095356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of excipients on the release kinetics of diclofenac sodium and papaverine hydrochloride from composed tablets.
    Kasperek R; Trebacz H; Zimmer Ł; Poleszak E
    Acta Pol Pharm; 2014; 71(3):439-49. PubMed ID: 25265824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.